Search dm+d | This VMP cannot be matched against our prescribing data.
Name | Galsulfase 5mg/5ml solution for infusion vials |
BNF code | 0908010AGAAAAAA |
Virtual Therapeutic Moiety | Galsulfase |
Date identifier became valid | 30 Oct 2018 |
Previous product identifier | 419538005 |
Basis of preferred name | rINN - Recommended International Non-proprietary |
Date of name applicability | 19 Jan 2009 |
Previous name | Galsulfase 5mg/5ml solution for injection vials |
Basis of previous name | rINN - Recommended International Non-proprietary |
Reason for name change | Other |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 5.000 |
Unit dose form units | ml |
Unit dose unit of measure | vial |
Virtual Product Ingredient | |
---|---|
Ingredient | Galsulfase |
Basis of pharmaceutical strength | Based on Ingredient Substance |
Strength value numerator | 1.000 |
Strength value numerator unit | mg |
Strength value denominator | 1.000 |
Strength value denominator unit | ml |
Ontology Drug Form & Route | |
Form & Route | solutioninfusion.intravenous |
Dose Form | |
Formulation | Solution for infusion |
Drug Route | |
Route | Intravenous |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
Naglazyme 5mg/5ml solution for infusion vials (BioMarin (U.K.) Ltd) | |
Virtual Medicinal Product Packs | |
Galsulfase 5mg/5ml solution for infusion vials 1 vial |
dm+d data retrieved from TRUD: release NHSBSA_11.1.0_20241111000001, imported on 12th November 2024 at 03:53:04.